HPLC column NUCLEODUR ® C 8 Gravity, 3 µm, 150 mm, 4.6 mm
Order number: 343K.1
Part number: AC100008461
£ 851.40*
*Prices plus VAT plus shipping costs£ 1021.68*
*incl. VAT, plus shipping costsPrice Breakdown
1
6
24
Prepared for use in regulated laboratory conditions, the HPLC column NUCLEODUR® C 8 Gravity offers exceptional performance for reversed phase separations. With a particle size of 3 μm and a specific surface area of 340 m²/g, this column provides excellent efficiency and resolution. Its base deactivated (BDS) surface chemistry and high density monomeric octyl (C 8 , MOS) modification ensure minimal unwanted polar interactions, making it ideal for the separation of basic and other ionizable analytes. The column's enhanced pH stability, LC/MS suitability, and superior base deactivation make it an excellent choice for method development and valuable for RP applications across various industries including pharmaceuticals, agrochemicals, and forensics.
- Category: Separation columns for HPLC
- Similar phases: NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8
- Surface chemistry: Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification
- Column type: HPLC column
- Eluent in column: Acetonitrile - Water
- Particle size: 3 µm
- Column shape: Analytical separation column
- Interactions / retention mechanism: hydrophobic (van der Waals)
- Pore size: 110 Å
- USP listing: L7
- Recommended application(s): In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals
- Column volume: 2.5 ml
- Temperature stability: 60 ° C
- Pore volume: 0.9 ml/g
- Specific surface according to BET: 340 m²/g
- Separation principle: Reversed phase (RP)
- Particle type: Fully porous particles (FPP)
- L x Ø internal (column): 150 x 4.6 mm
- Endcapped: yes
- pH stability: 1,0-11,0
- Phase: C 8 Gravity
- Pressure stability: 600 bar
| Name | Value | |
|---|---|---|
| Phase | : | C 8 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | HPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L7 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 2.5 ml |
| Particle size | : | 3 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8 |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification |
| Pressure stability | : | 600 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 150 x 4.6 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
